BSEIndrayani Biotech LtdMediumNeutral
Announced Tue, 21 Apr · 13:14 IST

Intimation of ISIN for Rights Entitlement to be credited for the purpose of Rights Issue of Indrayani Biotech Limited

Fund Raising View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+1.3%1-day move
₹12.00
prior close
₹12.18
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1+0.1+0.2+0.2+1.3+0.6+0.8+1.9-0.1-2.1-11.2-11.8-12.1-35.3
Up moveDown movePending
AI summary

Indrayani Biotech Limited has informed BSE about the ISIN (INE007C20013) for Rights Entitlement related to a partly paid-up rights issue. The face value of the equity shares is Rs. 10 with a paid-up value of Rs. 2.50 per share. The company references an earlier board meeting on 9th April 2026 that approved the key terms of this rights issue for eligible shareholders under the Companies Act, 2013 and SEBI (ICDR) Regulations, 2018. This is an administrative filing to formally register the ISIN for the rights entitlement with the exchange.

Likely market impact

This is a standard procedural intimation confirming the ISIN for trading of rights entitlements. The partly paid-up structure means shareholders will need to pay the balance amount in installments, which may be attractive to some investors but could also limit participation.